Literature DB >> 3679213

Three new orosomucoid (ORM) variants revealed by isoelectric focusing and print immunofixation.

S Weidinger1, T Müller, F Schwarzfischer, H Cleve.   

Abstract

Phenotypes of orosomucoid (ORM) in human sera have been analysed by isoelectric focusing and print immunofixation. After neuraminidase treatment the band patterns indicated that the polymorphism of the structural locus ORM1 is controlled by three autosomal codominant alleles. According to the previous nomenclature they were called ORM1F1, ORM1F2, and ORM1S. In a study of 272 unrelated individuals from southern Germany, five of the six expected common ORM1 subtypes were observed. Furthermore, we found three ORM variant phenotypes which have not been reported previously. These variants were characterized by additional bands in a cathodal position. One variant had additional double bands and presumably represents a rare ORM1 variant named ORM1S1. Two variants had additional single bands. They were assigned tentatively to the ORM2 gene locus. While the common gene product of ORM2 may be called ORM2A, the two variants are named ORM2B1 and ORM2B2, respectively. ORM2B1 has, thus far, been found only in a single individual; the variants ORM1S1 and ORM2B2 were found in a father-child pair and a mother-child pair, respectively. The frequency for variants tentatively assigned to the ORM2 locus is very low and was calculated to be 0.0037.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3679213     DOI: 10.1007/bf00284488

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  VARIANTS OF ALPHA-1-ACID GLYCOPROTEIN.

Authors:  K TOKITA; K SCHMID
Journal:  Nature       Date:  1963-10-19       Impact factor: 49.962

2.  Polymorphism of alpha1-acid glycoprotein.

Authors:  K SCHMIDT; J P BINETTE
Journal:  Nature       Date:  1961-05-13       Impact factor: 49.962

3.  Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13, and alpha 1-acid glycoprotein to chromosome 9.

Authors:  M Rocchi; L Roncuzzi; R Santamaria; N Archidiacono; L Dente; G Romeo
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

4.  delta-Aminolevulinatedehydrase: synteny with ABO-AK1-ORM (and assignment to chromosome 9).

Authors:  H Eiberg; J Mohr; L S Nielsen
Journal:  Clin Genet       Date:  1983-02       Impact factor: 4.438

5.  The microheterogeneity of human plasma alpha1-acid glycoprotein.

Authors:  E G Berger; S R Wyss; R B Nimberg; K Schmid
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-10

6.  Inheritance of human alpha-1-acid glycoprotein (orosomucoid) variants.

Authors:  A M Johnson; K Schmid; C A Alper
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

7.  Orosomucoid (ORM) typing by print lectinofixation: a new technique for isoelectric focusing. Two common alleles in Japan.

Authors:  K Umetsu; N Ikeda; S Kashimura; T Suzuki
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  Direct assignment of orosomucoid to human chromosome 9 and alpha 2HS-glycoprotein to chromosome 3 using human fetal liver x rat hepatoma hybrids.

Authors:  D W Cox; U Francke
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Orosomucoid (ORM) typing by isoelectric focusing: evidence of two structural loci ORM1 and ORM2.

Authors:  I Yuasa; K Umetsu; K Suenaga; M Robinet-Levy
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

  9 in total
  9 in total

1.  Genetic polymorphism of orosomucoid (ORM1 and ORM2) in Lombardy (Italy).

Authors:  N Cerri; F De Ferrari
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

2.  Orosomucoid (ORM) typing by isoelectric focusing: description of two new alleles in a German population and thermostability in bloodstains.

Authors:  K Umetsu; I Yuasa; K Nishi; B Brinkmann; T Suzuki
Journal:  Z Rechtsmed       Date:  1989

3.  Genetic polymorphisms of orosomucoid ORM1 and ORM2 in a Japanese population: occurrence of new ORM1 alleles.

Authors:  I M Sebetan; K Sagisaka
Journal:  Z Rechtsmed       Date:  1989

4.  Bound, free, and total L-dopa measurement in plasma of Parkinson's disease patients.

Authors:  Thomas Müller; Hans Michael Thiede
Journal:  J Neural Transm (Vienna)       Date:  2019-08-08       Impact factor: 3.575

5.  Use of transgenic mice for the characterization of human alpha 1-acid glycoprotein (orosomucoid) variants.

Authors:  L Tomei; C B Eap; P Baumann; L Dente
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

6.  Orosomucoid (alpha-1 acid glycoprotein) phenotyping by use of immobilized pH gradients with 8 M urea and immunoblotting. A new variant encountered in a population study.

Authors:  C B Eap; C Cuendet; P Baumann
Journal:  Hum Genet       Date:  1988-10       Impact factor: 4.132

7.  AIDS: no association with the genetic systems GC (D-binding protein), ORM (orosomucoid = alpha-1-acid glycoprotein), and A2HS (alpha-2-HS-glycoprotein).

Authors:  H Cleve; S Weidinger; L G Gürtler; F Deinhardt
Journal:  Infection       Date:  1988       Impact factor: 3.553

8.  Orosomucoid (ORM 1) subtyping and formal genetics.

Authors:  C Luckenbach; J Kömpf; H Ritter
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

9.  Orosomucoid (ORM) typing by isoelectric focusing: evidence for an additional duplicated ORM1 locus haplotype and close linkage of two ORM loci.

Authors:  I Yuasa; K Umetsu; K Suenaga
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.